retatrutide clinical status Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide, an investigational triple hormone

Clinically tested and proven In a recent 10-week clinical trial, participants experienced significant improvements in weight loss, digestion, energy, and appetite control.* 83% lost weight within 10 weeks 82% reduced food cravings within the first week 90% saw significant relief from bloating by week two 83% reported higher energy levels by week three *Clinical results are based on a self-reported survey conducted over 10 weeks with ColonBroom Premium

20 (Suppl

Blog Author: Dr

"By opening up about her own health, Serena is opening doors for millions of people who have felt shamed for needing support to lose weight," said Zach Reitano, co-founder and CEO of Ro